As per MRFR analysis, the Hemiplegia Market Size was estimated at 4.75 (USD Billion) in 2022. The Hemiplegia Market Industry is expected to grow from 5.08 (USD Billion) in 2023 to 9.2 (USD Billion) by 2032. The Hemiplegia Market CAGR (growth rate) is expected to be around 6.82% during the forecast period (2024 - 2032).
Innovations in technology in the field of rehabilitation, which include virtual reality therapy, and robotics are changing how hemiplegia is treated for good. These technologies provided unique opportunities to enhance motor functions, boost neuroplasticity and improve recovery mechanisms. Also, the most recent neurorehabilitation advances, such as stem cells research and targeted neuromodulation studies are highly effective for the development of the field in future. It is important for the players in the hemiplegia market to get the attention on these trends and utilize them to create and offer promising solutions which will assuredly help hemiplegia patients.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Hemiplegia is mainly caused by stroke, and its prevalence is increasing worldwide. According to the World Health Organization, about 15 million people suffer from stroke each year, making it the second leading cause of death. The increasing prevalence of strokes is mainly attributed to the increasing prevalence of risk factors such as hypertension, diabetes, and obesity. As people age, their risk of getting stroke increases since the risk factors are most common in old patients.The increasing prevalence of stroke is expected to drive the growth of the Hemiplegia Market Industry in the forecast period.
Technological advances are playing a significant role in the growth of the Hemiplegia Market Industry. The development of new and innovative devices and therapies is improving the outcomes for patients with hemiplegia. For instance, robotic rehabilitation devices are becoming increasingly popular as they provide intensive and repetitive therapy, which can help patients regain motor function. Additionally, advances in brain-computer interfaces (BCIs) are allowing patients with severe hemiplegia to control assistive devices with their thoughts.These technological advancements are expected to continue to drive the growth of the Hemiplegia Market Industry in the coming years.
There is increased awareness of hemiplegia and its effects on the lives of patients. This is especially due to the effort of patient groups and medical experts. As awareness of this issue continues to grow, more people are being diagnosed and put under treatment. This is resulting in high demand for rehabilitative services and other supportive devices. Anticipated increase in this awareness will be a major driver of this industry and market globally over the forecasted period.
The Hemiplegia Market segmentation by Type of Stroke can be bifurcated into Ischemic Stroke and Hemorrhagic Stroke. Ischemic Stroke, accounting for the dominant share of over 85% of all stroke cases globally, occurs when blood flow to a part of the brain is blocked, leading to tissue damage and impaired brain function. Hemorrhagic Stroke, on the other hand, arises from the rupture of a blood vessel in the brain, causing bleeding and subsequent damage to surrounding brain tissue. The prevalence of Ischemic Stroke is significantly higher than Hemorrhagic Stroke, primarily due to the influence of modifiable risk factors such as hypertension, high cholesterol, obesity, smoking, and physical inactivity.The Hemiplegia Market revenue for Ischemic Stroke is projected to surpass USD 4.3 billion by 2024, expanding at a CAGR of approximately 6.5%. The increasing incidence of cardiovascular diseases, coupled with the aging population worldwide, is expected to drive market growth in the coming years. In contrast, Hemorrhagic Stroke accounts for a smaller share of the Hemiplegia Market, with an estimated revenue of around USD 820 million in 2024.
The incidence of Hemorrhagic Stroke is influenced by factors such as uncontrolled hypertension, certain genetic disorders, and the use of blood thinners.The market for Hemorrhagic Stroke is anticipated to grow at a CAGR of approximately 5.8% during the forecast period, influenced by rising healthcare expenditure and advancements in treatment modalities. Understanding the segmentation dynamics of the Hemiplegia Market, particularly the Type of Stroke segment, is crucial for stakeholders to develop targeted strategies and allocate resources effectively. By leveraging market data and insights, companies can gain a competitive edge and tailor their offerings to meet the specific needs of patients with different stroke types.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Hemiplegia Market is segmented by Device Type into Passive Devices, Active Devices, and Neuroprosthetics. Among these, the Passive Devices segment held the largest market share in 2023, owing to the high adoption of these devices for providing support and stability to the affected limbs. Active Devices, on the other hand, are expected to witness the highest growth rate during the forecast period, due to the increasing demand for advanced and innovative technologies for rehabilitation and recovery. Neuroprosthetics, although a relatively nascent segment, is projected to gain significant traction in the coming years, owing to the advancements in brain-computer interfacing and the potential for restoring motor function in paralyzed individuals.The Hemiplegia Market revenue for Passive Devices is expected to reach USD 2.5 billion by 2032, while the market for Active Devices is projected to grow to USD 1.8 billion by the same year. Neuroprosthetics, with its promising potential, is estimated to reach a market value of USD 0.4 billion by 2032.
The Hemiplegia Market is segmented into rehabilitation, prevention, and diagnosis. Among these segments, the rehabilitation segment is expected to hold the largest market share in 2023. The growth of this segment can be attributed to the increasing number of stroke survivors and the rising demand for rehabilitation services. The prevention segment is also expected to witness significant growth in the coming years due to the growing awareness of hemiplegia and the availability of preventive measures. The diagnosis segment is expected to grow at a steady pace due to the increasing use of advanced diagnostic techniques.
The regional segmentation of the Hemiplegia Market offers valuable insights into the market's geographic distribution and growth dynamics. North America holds a dominant position in the market, accounting for a significant share of the Hemiplegia Market revenue due to well-established healthcare infrastructure, high prevalence of hemiplegia, and government initiatives to support research and development. Europe follows closely, driven by a large patient population, advanced medical facilities, and government funding for healthcare.The Asia Pacific (APAC) region is expected to witness substantial growth in the coming years, owing to increasing awareness of hemiplegia, rising healthcare expenditure, and the presence of a large population base. South America and the Middle East and Africa (MEA) regions are also projected to contribute to market growth, albeit at a slower pace, due to developing healthcare systems and increasing healthcare investments. By understanding the regional dynamics and growth prospects, stakeholders can tailor their strategies to target specific markets and maximize their market share.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Major players in Hemiplegia Market industry are continuously striving to develop innovative treatment methods for hemiplegia, thereby driving the growth of the market. For instance, in 2023, Bomedus Inc. announced the completion of its pre-IND meeting with the FDA for its lead asset, BMT-270, which is being developed for the treatment of plegia and paralysis. This highlights the ongoing efforts within the Hemiplegia Market to introduce advanced treatment options for patients. Leading Hemiplegia Market players are actively involved in research and development activities to expand their product portfolio and gain a competitive edge.One of the leading companies in the Hemiplegia Market is ReWalk Robotics Ltd. The company offers a range of exoskeleton devices for patients with lower limb disabilities. Its ReWalk Personal 6.0 exoskeleton system is a wearable device that allows users to stand upright, walk, and climb stairs independently. The company has a global presence and has established distribution partnerships in various countries. It is also focused on continuous product development and innovation to enhance the functionality and efficacy of its exoskeleton devices.A prominent competitor in the Hemiplegia Market is Ekso Bionics Holdings, Inc. The company is known for its EksoNR robotic exoskeleton, which is used for rehabilitation and assistance during walking. Ekso Bionics has partnered with leading healthcare providers and rehabilitation centers worldwide to offer its exoskeleton technology to patients. The company is actively involved in clinical research and development to validate the effectiveness of its exoskeleton system and expand its applications. It also provides training and support programs to ensure optimal utilization of its devices.
The Hemiplegia Market is projected to reach USD 9.2 billion by 2032, exhibiting a CAGR of 6.82% during the forecast period. Rising prevalence of stroke, increasing geriatric population, and technological advancements in rehabilitation therapies are major factors driving market growth. Key recent developments include the introduction of novel rehabilitation devices such as robotic exoskeletons and virtual reality-based therapies. Additionally, government initiatives and support for stroke rehabilitation programs are expected to contribute to market expansion.
| Report Attribute/Metric | Details |
| Market Size 2022 | 4.75 (USD Billion) |
| Market Size 2023 | 5.08 (USD Billion) |
| Market Size 2032 | 9.2 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | 6.82% (2024 - 2032) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2023 |
| Market Forecast Period | 2024 - 2032 |
| Historical Data | 2019 - 2023 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | CMS Therapy, ViNtAge Medical, Audentes Therapeutics, Patterson Medical, Hyperice, BTL Industries, Saebo Inc, DeRoyal Industries, Imalent, Vayu Therapeutics, Pensacola Sports Medicine. Inc, Ornamed, Ottobock, Neurolutions, Encompass Home Health |
| Segments Covered | Type of Stroke, Device Type, Application, Regional |
| Key Market Opportunities | Growing elder population Technological advancements in rehabilitation devices Rising prevalence of chronic diseases Increasing awareness about hemiplegia Government initiatives for rehabilitation programs |
| Key Market Dynamics | Aging population technological advancements increasing prevalence of stroke growing awareness of rehabilitation government initiatives |
| Countries Covered | North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Hemiplegia Market is expected to reach a valuation of 5.08 billion USD in 2023.
The Hemiplegia Market is projected to grow at a CAGR of 6.82% from 2023 to 2032.
The Hemiplegia Market is expected to reach a valuation of 9.2 billion USD by 2032.
North America is expected to hold the largest market share in the Hemiplegia Market throughout the forecast period.
The rehabilitation segment is expected to hold the largest market share in the Hemiplegia Market throughout the forecast period.
Some of the key competitors in the Hemiplegia Market include Ottobock, Stryker, and Zimmer Biomet.
The increasing prevalence of stroke and other neurological disorders is a major factor driving the growth of the Hemiplegia Market.
The high cost of treatment and the lack of skilled healthcare professionals are major challenges faced by the Hemiplegia Market.
The increasing use of robotics and AI in rehabilitation is a key trend emerging in the Hemiplegia Market.
The growing demand for personalized and remote rehabilitation services is a major growth opportunity for the Hemiplegia Market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
